Selegiline reduces daytime sleepiness in patients with Parkinson's disease.

Brain Behav · 2021 · PMC8119812 · PMID 33759401

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

borderline significanceno p-value reported

RESULTS We compared the scores from the three scales before and after 3 months of selegiline treatment and the differences were invariably significantly different (Table 2 ), with a borderline significance for the PDSS score.

also in 7,017 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.